Aparna Biosciences Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

Aparna Biosciences General Information

Description

Developer of biomedical nanoparticle technology and products for research and treatment of human disease. The company develops tissue targeting technology platforms that can advance biomedical research and ultimately revolutionary therapeutics.

Contact Information

Website
www.aparnabio.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 12111 Parklawn Drive
  • Suite 123
  • Rockville, MD 20852
  • United States
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Nanotechnology, TMT, Life Sciences
Corporate Office
  • 12111 Parklawn Drive
  • Suite 123
  • Rockville, MD 20852
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aparna Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Oct-2017 Completed Out of Business
2. Accelerator/Incubator 10-Aug-2011 Completed Startup
1. Grant 01-Sep-2009 $1.44M Completed Startup
To view Aparna Biosciences’s complete valuation and funding history, request access »

Aparna Biosciences Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Aparna Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2257280-A1 Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use Inactive 26-Feb-2008
US-20110312877-A1 Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use Inactive 26-Feb-2008
EP-2257280-A4 Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use Inactive 26-Feb-2008
US-9095568-B2 Therapeutic and vaccine polyelectrolyte nanoparticle compositions Inactive 26-Sep-2007
EP-2197457-A2 Therapeutic and vaccine polyelectrolyte nanoparticle compositions Inactive 26-Sep-2007 A61K31/575
To view Aparna Biosciences’s complete patent history, request access »

Aparna Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Aparna Biosciences FAQs

  • When was Aparna Biosciences founded?

    Aparna Biosciences was founded in 2007.

  • Where is Aparna Biosciences headquartered?

    Aparna Biosciences is headquartered in Rockville, MD.

  • What is the size of Aparna Biosciences?

    Aparna Biosciences has 4 total employees.

  • What industry is Aparna Biosciences in?

    Aparna Biosciences’s primary industry is Biotechnology.

  • Is Aparna Biosciences a private or public company?

    Aparna Biosciences is a Private company.

  • What is Aparna Biosciences’s current revenue?

    The current revenue for Aparna Biosciences is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »